Building better oncology tools
Company Overview
AccuStem is a clinical stage diagnostics company dedicated to optimizing outcomes and quality of life for all patients with cancer. We take a holistic view of our role in oncology- to empower patients and their care team with critical answers and tools that support more informed decision making.
Latest news
AccuStem Sciences, Inc. and EmeritusDX Announce Partnership to Commercialize MSC Test for Lung Cancer Screening
London, UK and Phoenix, AZ (April 28, 2025)- AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage [...]
AccuStem Sciences, Inc. Announces Chairman Purchase of Shares
London, UK and Phoenix, AZ, April 21, 2025 - AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical [...]
AccuStem Sciences, Inc. Signs Agreement to Access Blood Samples from Lung Cancer Screening Trial to Expedite MSC Commercialization Plan
London, UK and Phoenix, AZ (April 16, 2025)- AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage [...]
Information For Shareholders Regarding Accustem Shares
Holders of record of shares of Accustem Sciences Inc should refer to the below instructions regarding the process to receive their shares. Please contact Pacific Stock Transfer Company (“PSTC”) with any questions regarding the process.